Skip to content

Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study

Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03651674
Enrollment
200
Registered
2018-08-29
Start date
2018-09-20
Completion date
2020-04-01
Last updated
2018-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Bipolar Disorder

Brief summary

For more severe and treatment-resistant cases in schizophrenia and bipolar disorder, electroconvulsive therapy (ECT) is often very effective. The purpose of this study is to investigate the brain structure and function changes after ECT treatment. The neuroimaging marker which may predict the outcome of ECT is also studied in this research.

Interventions

Patients had bilateral temporal modified ECT four times a week for 3 consecutive weeks

Patients only have antipsychotic drugs

Sponsors

Xidian University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* International classification of diseases (ICD) diagnosis of Schizophrenia and bipolar disorder; * Ages 15-70 * All participants are ethnic Han * Not received ECT treatment before * PANSS ≥ 60 for schizophrenia subjects * The patient's written informed consent can be obtained. If the patient is incapacitated during the onset period, the written informed consent of the legal guardian is required.

Exclusion criteria

* Those with mental retardation, generalized developmental disorders,delirium, dementia, memory impairment or cognitive impairment that meet the diagnostic criteria of ICD-10; * Patients with cognitive impairment, such as Parkinson's, multiple sclerosis, stroke, and patients who meet the diagnostic criteria for ICD-10 alcohol dependence (except nicotine dependence); * The course of the disease is very short (fast phase inversion), such as 4 or more different mood abnormalities (depression, mild mania, mania, mental illness) in one year; * With severe unstable physical diseases; diagnosed diabetes, thyroid disease, hypertension, heart disease, etc.; * Narrow angle glaucoma; * With a history of epilepsy, except those with febrile seizures; * Have or have had drug-induced malignant syndrome and severe tardive dyskinesia; * With serious suicide attempts; * Cannot take medication as directed by their doctors, or who do not have guardians; * Pregnant or lactating women, or those who plan to become pregnant;

Design outcomes

Primary

MeasureTime frameDescription
Changes of Positive And Negative Syndrome Scale(PANSS)for Schizophrenia;3 time points: baseline, the end of the three-week treatment,3 months after ECT or drugs treatmentScales changes from baseline will be documented after three weeks treatment and 3 months follow-up visit.
Change of Bech-Rafaelsen Mania Rating Scale (BRMS) for Bipolar disorder3 time points: baseline, the end of the three-week treatment,3 months after ECT or drugs treatmentScales changes from baseline will be documented after three weeks treatment and 3 months follow-up visit.
Change of Hamilton Anxiety Scale (HAMA) for Bipolar disorder3 time points: baseline, the end of the three-week treatment,3 months after ECT or drugs treatmentScales changes from baseline will be documented after three weeks treatment and 3 months follow-up visit.
Change of Hamilton depression scale (HAMD) for Bipolar disorder3 time points: baseline, the end of the three-week treatment,3 months after ECT or drugs treatmentScales changes from baseline will be documented after three weeks treatment and 3 months follow-up visit.

Secondary

MeasureTime frameDescription
Changes of brain gray matter, white matter and functional based on MRI data analysis2 time points:baseline, the end of the three-week treatment]The changes of gray matter volume,structural integrity of white matter,and brain function during resting state after treatment will be analyzed.
Change of Mini-Mental State Examination3 time points: baseline, the end of the three-week treatment,3 months after ECT or drugs treatmentScale change from baseline will be documented after three weeks treatment and 3 months follow-up visit.

Contacts

Primary ContactWei Qin
wqin@xidian.edu.cn86-02981891070

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026